Quarterly Results

BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHBSE : 532989ISIN CODE : INE878I01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE96.814.61 (+5 %)
PREV CLOSE ( ) 92.20
OPEN PRICE ( ) 96.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2426
TODAY'S LOW / HIGH ( )96.70 96.81
52 WK LOW / HIGH ( )76.5 125.55
NSE94.804.5 (+4.98 %)
PREV CLOSE( ) 90.30
OPEN PRICE ( ) 94.80
BID PRICE (QTY) 94.80 (13950)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4679
TODAY'S LOW / HIGH( ) 94.80 94.80
52 WK LOW / HIGH ( )75.9 124.45
Quarters
Select year  
( in Million)
Particulars
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
131.33
109.25
115.65
68.49
Total Expenditure
88.88
107.04
119.41
97.16
PBIDT (Excl OI)
42.45
2.20
-3.75
-28.67
Other Income
-6.71
0.33
5.91
3.02
Operating Profit
35.74
2.53
2.15
-25.65
Interest
0.25
-1.01
0.45
1.27
Exceptional Items
-8.41
-217.17
NA
NA
PBDT
27.08
-213.62
1.70
-26.92
Depreciation
5.25
10.01
7.23
10.18
Profit Before Tax
21.83
-223.63
-5.52
-37.1
Tax
15.78
-0.35
0.4
-15.82
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
6.05
-223.28
-5.93
-21.28
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
6.05
-223.28
-5.93
-21.28
Minority Interest
-2.87
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
3.18
-223.29
-5.9
-21.28
Equity Capital
23.66
236.56
236.56
236.56
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
2.55
-9.43
-0.24
-0.89
Calculated EPS (Annualised)
10.21
-37.75
-0.99
-3.59
No of Public Share Holdings
1741143
17420470
17420470
17420470
% of Public Share Holdings
73.6
73.64
73.64
73.64
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
32.32
2.02
-3.25
-41.86
PBIDTM%
27.21
2.32
1.85
-37.45
PBDTM%
20.61
-195.53
1.46
-39.30
PBTM%
16.62
-204.69
-4.78
-54.16
PATM%
4.60
-204.37
-5.12
-31.07
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.